Severe pulmonary arterial hypertension in a very premature baby with bronchopulmonary dysplasia: Normalization with long-term sildenafil

Journal of Cardiovascular Medicine

Volumn 11, Issue 9, 2010, Pages 704-706

  Caputo, Salvatore ^a   Furcolo, Giuseppe ^b   Rabuano, Raffaello ^b   Basilicata, Angelo Maria ^b   Pilla, Luigi Maria ^b   De Simone, Alfredo ^b   Pasquariello, Brigida ^b   Ciampi, Quirino ^a   Vetrano, Gennaro ^b   Villari, Bruno ^a  

^a Division of Cardiology   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

bronchopulmonary dysplasia; preterm; pulmonary arterial hypertension; sildenafil

Indexed keywords

SILDENAFIL;

ABSENCE OF SIDE EFFECTS; ARTICLE; ASSISTED VENTILATION; CASE REPORT; DISEASE SEVERITY; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; INFANT; LONG TERM CARE; LUNG ARTERY PRESSURE; LUNG DYSPLASIA; MALE; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PULMONARY HYPERTENSION; TREATMENT DURATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRONCHOPULMONARY DYSPLASIA; DRUG ADMINISTRATION SCHEDULE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PIPERAZINES; PURINES; SEVERITY OF ILLNESS INDEX; SULFONES; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 77955187225     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328332e745     Document Type: Article

References (17)

1. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, et al. Very low birth weight outcomes of the National Institute of Child health and Human Development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001; 107:E1.
2. Abman SH. Bronchopulmonary dysplasia: a 'vascular hypothesis'. Am J Respir Crit Care Med 2001; 164:1755-1756.
3. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007; 120:1260-1269.
4. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163:1723-1729.
5. Jobe AH. The new BPD: an arrest of lung development. Pediatr Res 1999; 46:641-643.
6. Wilson WL, Mullen M, Olley PM, Rabinowitch M. Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery. Pediatr Res 1985; 19:1059-1067.
7. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999; 160:1333-1346.
8. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, Thebaud B. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 2005; 172:750-756.
9. Lassus P, Turanlahti M, Hiekkila P, Andersson LC, Nupponen I, Sarnesto A, Anderson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 2001; 164:1981-1987.
10. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Mctlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164:1971-1980.
11. Maniscalco WM, Watkins RH, D'Angio CT, Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Cell Mol Biol 1997; 16:557-567.
12. Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffe RB. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not in vascular endothelium: implications for mode of action. J Clin Endocrinol Metabol 1994; 79:316-322.
13. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18:4-25.
14. Klekamp JG, Jarzecka K, Perkett EA. Exposure to hyperoxia decreases the expression of VEGF and its receptors in adult rat lungs. Am J Pathol 1997; 154:823-831.
15. Zhang R, Wang L, Zhang L, Chen J, Zhu Z, Chopp M. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res 2003; 92:308-313.
16. Lakshminrusimha S, Steinhorn RH. Pulmonary vascular biology during neonatal transition. Clin Perinatol 1999; 26:601-619.
17. McCurnin DC, Pierce RA, Gibson LL, Osborne-Lawrence S, Yoder BA, Kereeman JD, et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2005; 288:L450-L459.